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mmHg ·beats/min·l 03, respectively). The normaI subjects were younger than
those with exercise-induced ST depression (37 ± 3 vs 57 ± 3 years, p < 0.01).
Conclusions: Endothelin-l, a potent vasoconstrictor, falls with exercise in
normal subjects, but increases in patients with exercise-induced ST segment
depression. Endothelin-l may be one of the mediators of exercise-induced
coronary insufficiency.
8:45
1780-21 Exercise Increases Systemic Nitric Oxide Production
in Men
Stefanie M. Bode-Boger, Rainer H. Boger, Jurgen C Frolich Institute of Clinical
Pharmacology, Medical School. Hannover; Germany
The effects of submaximal exercise on systemic nitric oxide (NO) formation,
as assessed by measuring the urinary excretion rates of NO; and of cyclic
GMP. were compared in 10 endurance-trained and 6 untrained male subjects.
Urinary excretion rates of NO; (by gas chromatography) and cyclic GMP (by
radioimmunoassay) were assesse before and after a 30 min exercise tes1dlt
60% of each subject's individual maximal work capacity in hourly intervals.
Urinary NO; excretion in untrained and trained subjects was comparable at
rest (104 ± 35 vs. 110 ± 19 /lmol/mmol creatinine, p = n.s.). It more than
doubled during exercise in both groups (to 236 ± 88 /lmollmmol creatinine in
untrained and to 252 ± 39 /lmol/mmol creatinine in trained subjects, each p
< 0.01) and rapidly decreased to baseline within 2 hours after the test. Rest-
ing urinary cyclic GMP excretion was fourfold higher in the athletes than in
the untrained subjects (21 ± 5 vs. 6 ± 1 nmollmmol creatinine, p < 0.05).
During exercise it increased about twofold in both groups (to 52 ± 12 and
10 ± 1 nmollmmol creatinine, respectively, each p < 0.01), and returned to
baseline after its end. There was a correlation between urinary cyclic GMP
and NO- excretion (p < 0.05) in both groups. We conclude that acute sub-
maximaT exercise increases the formation of NO in man, as reflected by the
increased urinary excretion of NO; and cyclic GMP. This may contribute to
the vasodilation during physical exercise, and at least partly explain the ben-
eficial effects of physical training in patients with cardiovascular diseases.
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1780-31 Does Estrogen Reduce the Accuracy of Exercise
Electrocardiography in Women?
Anthony P. Morise, Robert Beto, George A. Diamond. West Virginia University,
Morgantown, WV
It has been suggested that estrogen has a role in the genesis of false posi-
tive exercise electrocardiograms in women. We evaluated 1007 men and 832
women with suspected coronary artery disease concerning the accuracy of
exercise electrocardiography. Women were grouped according to estrogen
status (ES): ES- = postmenopausal and not on estrogen replacement and
ES+ = premenopausal (Premen) or on estrogen replacement. Positive exer-
cise ST criteria were 2:1 mm horizontal/downsloping or 2:1.5 mm upsloping
depression. Results: Overall accuracy: sensitivity 44% and specificity 87%;
receiver operating characteristic curve (ROC) area 76 ± 3. The following table
compares the accuracy of men and subgroups of women.
Number Sensitivity Specificity ROC Area
Men t007 52 ± 7 91 ± 2 84 ± 3
Women 832 34 ± 7 82 ± 2' 64 ± 6'
ES- 317 35 ± 12 79 ± 5' 61 ± 9'
ES+ 515 15± 11 81 ± 2' 46 ± 15'
Premen 259 72 ± 40 91 ± 5" 90 ± 14'
'p < 0.01 vs Men; "p ~ 0.05 vs ES+ or ES-; 'p < 005 vs Women, ES+, or ES-
The heart rate-pressure products for Men (26,600 ± 600) and Premen
(26,500 ± 500) were the same (p = 0.58).
Conclusion: Concerning exercise electrocardiography, both ES+ and ES-
women have lower accuracy than men. However, Premen women (a sub-
group of ES+) had exercise performance and accuracy similar to men, espe-
cially concerning specificity. These results suggest that not all ES+ women
have the same accuracy and argue against a role for naturally occurring es-
trogen as an etiology for false positive results.
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1780-41 ST Segment Depression Risk, Menopause,
Hysterectomy and Exogenous Estrogen in
Asymptomatic Women
Arlan J. AI-Hani, Alice Furumoto-Dawson Sf James Hospital & Health Centers,
Chicago Heights, IL
In a 1993 follow-up survey, the Women Take Heart Project assessed 1992
menopausal status, including hysterectomy, and validated exogenous estro-
gen use (both estrogen replacement therapy and birth control pills) in 5932
women (W) who were examined and treadmill stress tested during 1992.
5449 W provided complete data for these analyses.
Using logistic regression to estimate the relative likelihood of significant ST
segment depression (1 mm at 80 msec) while taking into account age, body
mass index (kg/m2), cholesterol, resting heart rate, supine systolic blood
pressure (SSP, mmHg). educational attainment and weekly aerobic exercise
frequency as continuous variables, and employment, black race and smok-
ing as categorical factors, the effects of estrogen and menopausal status
(pre-menopausal: Pre, menopausallpost: M, and hysterectomy: Hyst) were
examined. Hyst-W were younger than M-W at examination (mean age 56.4
vs. 59.3). and their mean age at hysterectomy was younger than either the
mean age of menopause onset or completion that M-W reported (41 vs. 47
and 50 years old). The overall fit of the model was highly significant (model
chi-square with 14 df = 211.67, P < 0.0001).
Variable B S.E. df Sig Odds Ratio
Age (each addtl yr) 0.009 00047 1 0.0493 1.01
Estrogen Use 0.372 0.0775 1 0.0000 1.45
Reprod Status Overall 3 0.004B
(Pre-menopause: reference category) 1.00
Menopausal/post 01B7 0.05B2 0.0013 1.21
Late hyst «35 yrs) 0.114 0.0636 00725 1.12
Early hyst -0.254 0.0924 0.0059 0.7B
Conclusions: 1) Post-menopausal status, independent of aging, appears
to increase women's cardiovascular disease risk. 2) Exogenous estrogen ap-
pears to increase women's likelihood of responding to exercise stress testing
with ST segment depression.
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1780-51 Training Level Comparison Study: Effects of Exercise
Training Intensity on Insulin and Glucose Levels in
Coronary Patients with "Clustering" of Risk Factors
Mary Ellen Sweeney, Gerald F. Fletcher, Albert Oberman, Barbara J. Fletcher,
Sandra B. Dunbar, Jeannette Lee, Claire R. Rice Emory University, Atlanta, GA;
University ofAlabama, Birmingham, AL
Hyperinsulinemia has been associated with clustering of hypertension, glu-
cose intolerance, elevated cholesterol and obesity. The effect of exercise
training (Ex Tr) intensity on serum glucose (G) and insulin (I) was studied
in 26 of 200 pts with documented coronary artery disease exhibiting risk
factor clustering. Pts were prospectively randomized to high intensity (85%
V02max) Ex Tr or low intensity (50% V02max) Ex Tr, 60 min., 3 x week.
Groups did not differ by age, weight, elevated cholesterol, hypertension or
glucose intolerance at baseline. G and I levels were analyzed in the fasting
state and 1 hour post glucose load at baseline and after 6 mo. of Ex Tr. Data
were analyzed byWilcoxin signed rank number test and reported as medians
with (ranges). There were no significant base to 6 mo. differences in fasting
G and I levels in either group.
Post glucose load results:
Base -=:6;..:M;..:O:.:.:-::-::-_-:-~_::-:-:::-:---:::
High Ex Tr(N = 14) Low Ex Tr (N = 12) High Ex Tr (N = 11 ) Low Ex Tr IN = B)
I (/lIU/ml) 136 137 66' 100
(9-532) (37-1305) 111-29B) (36-137)
G(mg/dl) 20B 197 17B" lB2
(161-50B) 167-400) 176-532) (137-1305)
'p ~ 0007 (within group), "p ~ 0.002 (within group)
We conclude high intensity Ex Tr appears more effective in altering post-
absorptive I and G levels in coronary pts exhibiting clustering of risk factors.
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Effect of Long Term Prostacyclin (PGI2) on Exercise
in Patients with Primary Pulmonary Hypertension
(PPH) Who Have Deteriorated on Maximal
Conventional Therapy
David F. Wax, Robert Garofano, Welton M. Gersony, Robyn J. Barst. Columbia
University, New York, NY
Continuous IV PGI2 has been shown to improve survival and quality of life in
patients with PPH. We used cycle ergometrywith continuous measurement
of gas exchange to evaluate 15 pts (6-57 yrs) with PPH who were treated
with PGI2 after having deteriorated on maximal conventional therapy (CT:
oral vasodilators, cardiac glycosides, diuretics, oxygen and anticoagulation).
Column I shows the performance while on maximal CT 2 to 13 mos before
starting PG12. Column 2 is the baseline performance immediately prior to
starting PGI2. Data are presented as mean ± SO.
